Here, we analyzed a glycoengineered gastric carcinoma cell line model that expresses SLex due to the overexpression of ST3Gal IV 12, in order to identify SLex protein carriers as novel biomarkers in gastric cancer. This evidence concerns the gene ST3GAL4 and gastric carcinoma.